USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/28560
Title: Clinical ”Odyssey” in Wilson's disease patients from the Republic of Moldova
Authors: Cumpata Veronica
Issue Date: 2024
Publisher: Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova
Citation: Cumpata Veronica. Clinical ”Odyssey” in Wilson's disease patients from the Republic of Moldova. In: Abstract Book. MedEspera 2024. The 10th International Medical Congress for Students and Young Doctors. 24-27 April 2024, Chișinău, Republic of Moldova, p. 139. ISBN 978-9975-3544-2-4.
Abstract: Introduction. Wilson's disease (WD) presents high clinical heterogeneity, independent of age and sex. In our country, it is the first study that analyzes the phenotype of patients with this genetic disorder. Aim of study. The study aims to evaluate the clinical features of patients with WD in the Republic of Moldova. Methods and materials. A retrospective and prospective study was performed on 170 people suspected of WD, between 2006 and 2023. The modified Leipzig Scoring System was used to specify the diagnosis; a score ≥ 4 points establishes the diagnosis of WD. All patients were genetically tested by the Sanger sequencing method. Statistical analysis was performed using EpiInfo. Results. Out of 170 people, 50 patients had a score of≥ 4 points. The mean age was 23 years ± 9.3 (range 5-46 years), and the median was 24.5 years. 23% of pts are <18 years old. The female/male ratio is 1:1.5. The average duration of the period of the diagnosis was 25.7 months (range 1-96 months). All persons were of Caucasian origin. No consanguineous relationships have been described. Hepatic onset was associated in 43.9%, in both sexes equally, while neurological onset was associated in 56.09%, predominating in men (73.09%). Patients with hepatic presentation are diagnosed at younger ages (17.67 years ± 9.07), while those with neuro-psychiatric type are diagnosed at older ages (27.39 years ± 7.81) and with longer diagnosis delays. After examination, liver disease was diagnosed in 52.17% of those with neurological onset; and in those with hepatic onset, neurological lesions were detected in 16.7%. In 58.82%, the liver phenotype was represented by liver cirrhosis (decompensated – 70%). The most frequent neurological manifestations were postural instability – 43.47%, pseudo-bulbar syndrome (dysphagia, dysarthria) - 35%, and tremors of the limbs - 30%. The psychiatric presentation includes depression - 47%, sleep disturbance - 25%, and mood changes - 17%. The Kayser-Fleischer ring was identified in 32%, of which 75% was associated with neurological lesions. Splenomegaly was identified in 58.54%, of which 79.17% were associated with hepatomegaly. One patient underwent a liver transplant due to acute liver failure. Genetic testing was performed in 92%, and most of them were compound heterozygotes. The most common mutation was p.H1069Q (69.57%). Conclusion. Our study observed that hepatic presentation was diagnosed at younger ages, while neuropsychiatric manifestations were identified at older ages and with longer diagnostic delays. Also, the late establishment of the diagnosis was associated with various complications and irreversible organic damage. sex. In our country, it is the first study that analyzes th e phenotype of patients with this genetic disorder. Aim of study. The study aims to evaluate the clinical features of pat ients with WD in the Republic of Moldova. Methods and materials. A retrospective and prospective study was performed on 170 peopl e suspected of WD, between 2006 and 2023. The modified Leipzig Scoring System was used to specify the diagnosis; a score ≥ 4 points establishes t he diagnosis of WD. All patients were genetically tested by the Sanger sequencing method. Statistica l analysis was performed using EpiInfo. Results. Out of 170 people, 50 patients had a score of≥ 4 points. The mea n age was 23 years ± 9.3 (range 5-46 years), and the median was 24.5 years. 23% of pts are <18 years old. The female/male ratio is 1:1.5. The average duration of the period of the dia gnosis was 25.7 months (range 1-96 months). All persons were of Caucasian origin. No consangui neous relationships have been described. Hepatic onset was associated in 43.9%, in both sex es equally, while neurological onset was associated in 56.09%, predominating in men (73.09%). Patient s with hepatic presentation are diagnosed at younger ages (17.67 years ± 9.07), while those wit h neuro-psychiatric type are diagnosed at older ages (27.39 years ± 7.81) and with longer di agnosis delays. After examination, liver disease was diagnosed in 52.17% of those with neurologic al onset; and in those with hepatic onset, neurological lesions were detected in 16.7%. In 58. 82%, the liver phenotype was represented by liver cirrhosis (decompensated – 70%). The mo st frequent neurological manifestations were postural instability – 43.47%, pseudo-bulbar s yndrome (dysphagia, dysarthria) - 35%, and tremors of the limbs - 30%. The psyc hiatric presentation includes depression - 47%, sleep disturbance - 25%, and mood changes - 17% . The Kayser-Fleischer ring was identified in 32%, of which 75% was associated with neurolog ical lesions. Splenomegaly was identified in 58.54%, of which 79.17% were associated with hepatom egaly. One patient underwent a liver transplant due to acute liver failure. Genetic testi ng was performed in 92%, and most of them were compound heterozygotes. The most common mutation was p.H1069Q (69.57%). Conclusion. Our study observed that hepatic presentation was diagnosed at younger ages, while neuropsychiatric manifestations were identified at older ages and with longer diagnostic delays. Also, the late establishment of the diagnosis was asso ciated with various complications and irreversible organic damage.
metadata.dc.relation.ispartof: MedEspera 2024
URI: https://ibn.idsi.md/collection_view/3104
http://repository.usmf.md/handle/20.500.12710/28560
ISBN: 978-9975-3544-2-4
Appears in Collections:MedEspera 2024

Files in This Item:
File Description SizeFormat 
MEsp24_139.pdf343.29 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback